Menu
Strategic Pathways Engagements
Clinical Pathways have become a crucial tool for providers and payers to standardize evidence-based care and manage costs. Being off or disadvantaged on pathways can limit brand perception, uptake, and utilization. With decades of experience in the pathways space, The Dedham Group offers comprehensive pathways support tailored to product needs at different stages of lifecycle in oncology and other therapeutic areas.
Learn more about the Dedham Group’s Pathways Expertise:
Evidence Requirement:
Gain insights into the pathways development process, evaluation criteria, and evidence requirements to secure favorable positioning within priority indications.
Data Generation & Submission Strategy:
Identify key endpoints and evidence sources (e.g., clinical trials, RWE) while adhering to best practices for data submission to enhance positioning post-approval.
Pathways Landscape Assessment:
Gain a comprehensive understanding of pathways trends, adoption, implementation, development, product positioning, and key stakeholders related to priority indications
TPP Testing & Threats / Opportunities:
Identify anticipated threats and opportunities through TPP testing, historical analogs, etc., to inform engagement priorities.
Customized Workshop / Training:
Develop and execute training sessions tailored to the audience (commercial vs. medical; HQ vs. field) to enhance internal buy-in and proficiency around pathways.
Engagement Model & Operational Planning:
Design a customized pathways engagement model, ensuring matrix team alignment, defining roles and responsibilities, and streamlining communication flow.
Pathways Dynamics Monitoring:
Regularly monitor changes in pathways and provide monthly/quarterly updates to guide evolving priorities.
PULSE Pathways Web Tool:
Utilize an interactive web tool with up-to-date pathways information and a monthly newsletter to support internal education and engagement planning.
Business Impact Evaluation:
Leverage data analytics to assess the impact of pathways management on business volume and market share over time.
Engagement Benchmarking & Model Optimization:
Identify internal gaps, best practices, and opportunities to optimize pathways engagement.
Competitive Scenario Planning:
Assess risks and opportunities upon competitive entrance and develop a defense strategy for optimizing pathways access.
Over 10 years of dedicated pathways experience, with a track record of 200+ pathways-related engagements in the past 5 years.
Leverage our proprietary in-house knowledge through PULSE Analytics, an up-to-date web-based tool offering robust databases and a monthly newsletter, ensuring you stay ahead in the dynamic pathways landscape.
From pathways landscape assessment and internal training to data analytics, strategy development, operational planning, and ongoing tracking, The Dedham Group provides end-to-end solutions
In recent years, healthcare providers, payers, and policymakers have increasingly shifted focus from delivering volume-based care to delivering value-based care. This transition, moving from traditional fee-for-service to models that prioritize quality and efficiency, has created a need for care models that deliver high-quality care while managing costs.
Learn how the Dedham Group helped a client understand the oncology pathways landscape.
© The Dedham Group, 2024. A Norstella Company
